Gram-Negative Organisms Account for Nearly One-Third of Spinal Fusion SSIs
A national CDC surveillance analysis has clarified a point spine surgeons have long suspected but rarely seen quantified at scale: gram-negative organisms are not a minor subset of postoperative spinal fusion infections. They caused 31.5% of spinal fusion surgical site infections in a 2021–2022 cohort of 7,187 cases reported to the National Healthcare Safety Network, a burden large enough to shape empiric therapy in the right clinical setting.
The microbiology was dominated by familiar skin and hospital pathogens. Staphylococcus species were the most common genus overall, and Staphylococcus aureus alone accounted for 30.6% of all cases. Even so, gram-negative bacteria were nearly as common, with Escherichia coli and Pseudomonas aeruginosa emerging as the leading species in that category. Fungal and mycobacterial infections were rare.
This is the kind of dataset that changes bedside thinking. When postoperative spinal hardware becomes infected, the organism profile is broader than a reflexive assumption of gram-positive disease would suggest.
Which Patients and Procedures Tilt Toward Gram-Negative Infection
The study separated infections into three analytic groups, using monomicrobial S. aureus as the reference category. Against that standard, several clinical and procedural variables tracked with gram-negative infection in a multivariable multinomial model.
Female sex carried higher odds of gram-negative infection. So did older age, higher body mass index, longer operative duration, greater comorbidity burden, lumbar involvement, trauma-related surgery, emergency surgery, and inpatient surgery. Outpatient procedures were less likely to be associated with gram-negative infection than the reference group. The relationship with postoperative timing also ran in a clear direction: the longer the interval from spinal fusion to infection diagnosis, the lower the odds that the case involved a gram-negative organism.
A few of these signals fit the clinical geography of spine surgery. Lumbar procedures sit closer to the bowel-rich lower trunk and often involve larger exposures, more instrumentation, and more complex wound environments than limited cervical operations. Trauma and emergency surgery can compress preoperative optimization, increase contamination risk, and prolong operative time, all of which may create a more hospitable setting for enteric or environmental gram-negative flora. Higher ASA class likely acts as a proxy for physiologic reserve and overall illness burden, marking patients who may tolerate less surgical stress and have more complex postoperative courses.
The operative-time signal was especially direct. Each additional hour increased the odds of gram-negative infection by 20% versus monomicrobial S. aureus infection. Longer procedures may translate into wider tissue exposure, more device handling, greater blood loss, and a longer window for bacterial inoculation. In hardware surgery, time is not just an efficiency metric; it is part of the infection biology.
The Microbiology Behind Empiric Coverage Decisions
Among all 7,551 unique microorganisms isolated from the cohort, gram-positive bacteria made up 53% of detections, but gram-negative organisms still represented a substantial fraction of the pathogen burden. The finding matters because empiric treatment for postoperative spinal fusion SSI often begins before culture finalization, especially when the patient is unstable, has deep hardware involvement, or has already received prior antibiotics.
In that setting, the pathogen profile matters more than academic taxonomy. A deep infection driven by Pseudomonas or an Enterobacterales species will not be managed adequately by a regimen aimed only at methicillin-resistant staphylococci. The data support broader initial coverage in patients whose profiles align with the higher-risk strata identified here, then narrowing once operative cultures return.
The authors also performed a secondary analysis restricted to monomicrobial gram-negative and monomicrobial S. aureus infections, and the main associations remained consistent. That strengthens the argument that the pattern is not simply an artifact of mixed infections or culture contamination. The same risk signals persisted when coinfection was stripped away.
One notable asymmetry emerged in the timing of diagnosis. Gram-negative infection was less likely as the interval from surgery to diagnosis lengthened, suggesting that these infections cluster earlier in the postoperative course. Early presentation may reflect more aggressive inoculation, faster clinical declaration, or a different wound ecology than later infections that are more often driven by other organisms.
Why This Matters for Spine Surgery and Infection Control
The study used deidentified National Healthcare Safety Network data from January 2021 through December 2022, making it one of the more contemporary national snapshots of spinal fusion SSI microbiology. A total of 294 cases were excluded because infection was already present at the time of surgery, leaving a cleaner postoperative cohort for analysis. Most procedures occurred in the inpatient setting, and most used a posterior approach, reflecting how spinal fusion is commonly delivered in the United States.
For infection prevention teams, the implications are practical. Patient selection, operative planning, perioperative antibiotics, and postoperative surveillance are all part of the same chain. When a case involves advanced age, obesity, lumbar instrumentation, trauma, or emergency surgery, the chance that a later SSI will involve gram-negative organisms rises enough to justify closer attention to empiric coverage strategy and to local susceptibility patterns.
The study does not argue for blanket gram-negative prophylaxis in every spine case. It does point to a narrower target: high-risk cohorts in whom the microbiology is more likely to extend beyond S. aureus. That is where future work will need to focus, especially if prophylactic regimens are expanded. The clinical question is not whether gram-negative pathogens matter in spinal fusion SSI; this dataset shows that they do. The unanswered issue is how best to use that knowledge without broadening antibiotic exposure beyond the patients most likely to benefit.